What do Biden’s drug price comparisons reveal? Not much

Plus: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy

August 15, 2024 Check out STAT+

Sponsored By

Rich Pedroncelli/AP STAT+ | Medicare announces drug prices for historic first round of negotiations Inflation Reduction Act negotiations cover 10 drugs: Eliquis, Xarelto, Januvia, Jardiance, Enbrel, Imbruvica, Farxiga, Entresto, Stelara and NovoLog By Rachel Cohrs Zhang Medicare drug price negotiation didn't benefit Biden — but it may help Harris Medicare negotiating lower drug prices is popular among voters. Kamala Harris cast the decisive tie-breaking vote, and every Republican voted against it. By John Wilkerson and Rachel Cohrs Zhang STAT+ | What do Biden's drug price comparisons reveal? Not much Medicare negotiations will lower drug prices, but precise savings are hard to estimate in a healthcare business mix of insurers, PBMs and drug companies. By Rachel Cohrs Zhang Adobe STAT+ | Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy The company also announced that Rich Doblin, the company's founder, would step down from its board. By Meghana Keshavan Antiviral used for mpox no better than placebo, NIH says Tecovirimat or TPOXX, developed for smallpox, proved disappointing for mpox, just as that virus is again declared a global health emergency. By Jason Mast STAT+ | The business of CRISPR'd medicine: Not great Today's biotech news roundup includes a look at the rollout of Casgevy, the genetically engineered cell therapy from Vertex and CRISPR Therapeutics. By Adam Feuerstein Brian Tietz for STAT Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs Switching from Humira or Xeljanz reduces out-of-pocket expenses but requires lengthy infusions and risks side effects. By Joseph Howlett and Andrea Tamayo

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser